Wednesday October 28, 2020

Cancer test too expensive for public patients

A new diagnostic test that would help many women with breast cancer avoid debilitating chemotherapy will not be made available to public patients because it is too expensive.

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
13th August, 2011
2
{ }

A new diagnostic test that would help many women with breast cancer avoid debilitating chemotherapy will not be made available to public patients because it is too expensive.

The National Centre for Pharmacoeconomics (NCPE)s aid the test should not be made available to public patients, and gave the high price of the test as the reason for this.

The new gene test was hailed as a breakthrough in breast cancer diagnosis by cancer specialists.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 9 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 5 years ago